UCB GmbH secures contract for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the active ingredient Romosozumab (Evenity)

Posted On: 2025-12-24

Germany, Dec. 24 -- Germany based UCB GmbH has secured contract from Vergabekammer des Bundes beim Bundeskartellamt for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the active ingredient Romosozumab (Evenity). The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

UCB GmbH secures contract for Pharmaceutical products - Announcement of orders awarded in accordance with Section 130 a Paragraph 8 SGB V and Section 130 c SGB V for the active ingredient Romosozumab (Evenity)